April Bell Selected Research

Proteins (Proteins, Gene)

12/2022	Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma.
12/2021	Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

April Bell Research Topics

Disease

6	Brain Neoplasms (Brain Tumor) 12/2023 - 01/2020
5	Glioblastoma (Glioblastoma Multiforme) 12/2022 - 01/2020
4	Neoplasms (Cancer) 12/2021 - 01/2020
1	Glioma (Gliomas) 10/2020

Drug/Important Bio-Agent (IBA)

2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 12/2022 - 10/2020
2	EnzymesIBA 12/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 12/2022 - 12/2021
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 10/2020
2	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 10/2020 - 01/2020
1	SenotherapeuticsIBA 12/2023
1	snake venom protein C activatorIBA 12/2022
1	Complement Factor H (Factor H)IBA 12/2021
1	Tryptophan (L-Tryptophan)FDA Link 12/2021
1	Protein Isoforms (Isoforms)IBA 12/2021
1	Immune Checkpoint InhibitorsIBA 10/2020

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2020
2	Immunotherapy 12/2023 - 12/2021
1	Aftercare (After-Treatment) 12/2023